Bioventus (BVS)
(Delayed Data from NSDQ)
$9.92 USD
+0.04 (0.40%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $9.93 +0.01 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $0.06 | 0.00% |
Earnings Summary
For their last quarter, Bioventus (BVS) reported earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.07 per share. This reflects a positive earnings surprise of 171.43%. Look out for BVS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of $0.06 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for BVS
Galapagos (GLPG) Up on FDA Nod to Begin Phase I/II Lymphoma Study
BVS: What are Zacks experts saying now?
Zacks Private Portfolio Services